Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with inflammation in systemic sclerosis

被引：0
|
作者：
Rutella, Sergio [1 ,2 ]
De Santis, Maria [1 ]
Bonanno, Giuseppina [1 ]
Procoli, Annabella [1 ]
Mariotti, Andrea [1 ]
Corallo, Maria [1 ]
Novarese, Linda [1 ]
Bosello, Silvia [1 ]
Scambia, Giovanni [1 ]
De Cristofaro, Raimondo [1 ]
Ferraccioli, Gianfranco [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Sch Med, Rome, Italy
[2] IRCCS San Raffaele Pisana, Rome, Italy
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
115.5
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Indoleamine 2,3-dioxygenase 1 (IDO1) activity arrests the apoptosis of Mycobacterium tuberculosis (M. tuberculosis)-infected macrophages
    Guo, Lihui
    Hollestelle, Bente
    Tromp, Samantha A. M.
    Dijkhuis, Annemiek
    Lutter, Rene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [42] Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
    Williams, David K.
    Markwalder, Jay A.
    Balog, Aaron J.
    Chen, Bin
    Chen, Libing
    Donnell, Jennifer
    Haque, Lauren
    Hart, Amy C.
    Mandal, Sunil K.
    Nation, Andrew
    Shan, Weifang
    Vite, Gregory D.
    Covello, Kelly
    Hunt, John T.
    Jure-Kunkel, Maria N.
    Seitz, Steven P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 732 - 736
  • [43] Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
    Yang, Minyan
    Huang, Guanyou
    Qian, Hua
    Wang, Jun
    Zhao, Shuyun
    Li, Shixiang
    Yuan, Yan
    AUTOIMMUNITY, 2021, 54 (03) : 156 - 162
  • [44] Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
    Lee, Dong-Ho
    Lee, Joo-Youn
    Jeong, Jieun
    Kim, Miok
    Lee, Kyung Won
    Jang, Eunseo
    Ahn, Sunjoo
    Lee, Chang Hoon
    Hwang, Jong Yeon
    MOLECULES, 2017, 22 (11):
  • [45] Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers
    Komiya, Takefumi
    Huang, Chao H.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [46] Indoleamine 2,3-dioxygenase 1 (IDO1) Blood Metabolites May Improve Predictive Accuracy for Radiation Pneumonitis
    Meng, Y.
    Liu, J.
    Chen, W.
    Yang, H.
    Kong, F.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S626 - S626
  • [47] Discovery of novel and potent inhibitors of indoleamine-2,3-dioxygenase (IDO1) for cancer immunotherapy
    Liu, Shengyang
    Tao, Taoliangshan
    Liang, Yue
    Guo, Hongli
    Ye, Xiaogang
    Wu, Zhiheng
    Bao, Fang
    Yang, Heping
    Cai, Yaxian
    Yang, Gangjing
    Wang, Longsheng
    Liu, Fang
    Fu, Guangliang
    Liu, Xiaolei
    Du, Jiangang
    Qin, Ping
    Ma, Yuanfei
    Zhu, Panhu
    Yu, Yajun
    Ma, Chen
    Wang, Pei
    Zhao, Liping
    Wang, Yuxun
    Gao, Daxin
    Li, Qun
    CANCER RESEARCH, 2016, 76
  • [48] Identification of putative Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) dual inhibitors for triple-negative breast cancer therapy
    Paranthaman, Priyanga
    Veerappapillai, Shanthi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025,
  • [49] A novel class of inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1) with potential for the treatment of cancer
    Ching, Lai-Ming
    Palmer, Brian D.
    Tomek, Petr
    Flanagan, Jack U.
    Henare, Kimiora
    CANCER RESEARCH, 2015, 75
  • [50] Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity
    Arefayene, Million
    Philips, Santosh
    Cao, Donghua
    Mamidipalli, Sudharani
    Desta, Zeruesenay
    Flockhart, David A.
    Wilkes, David S.
    Skaar, Todd C.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (06): : 464 - 476
12345